Business Context and Reporting Period
Company: Prothena Corporation plc (PRTA)
Filing Type: Form 8-K (Current Report)
Date of Report: December 23, 2021
Event: Entry into an Equity Distribution Agreement to facilitate an "at-the-market" offering of Ordinary Shares.
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data point disclosed is the potential capital raise:
- Maximum Offering Size: Up to $250.0 million in aggregate offering price.
- Commission Rate: Up to 3.0% of aggregate gross proceeds paid to agents.
Material Changes
The material change reported is the execution of a new Equity Distribution Agreement with Piper Sandler & Co., Stifel, Nicolaus & Company, Incorporated, Cantor Fitzgerald & Co., RBC Capital Markets, LLC, and JMP Securities LLC. This agreement authorizes the Company to sell Ordinary Shares from time to time through the agents, subject to market conditions and Company discretion.
Guidance, Outlook, and Risks
Management Commentary: The Company is not obligated to sell any shares under the agreement and may instruct agents to halt sales if prices fall below designated levels. The offering terminates upon the sale of all shares or termination of the agreement.
Risks and Contingencies: The filing includes forward-looking statements regarding the ability to raise funds. Actual results may differ due to market conditions, satisfaction of pre-sale conditions, and inherent business risks. The Company undertakes no obligation to update these statements.
Investor Verification Checklist
- Verify the current market price of PRTA Ordinary Shares to assess the potential dilution impact of a $250 million offering.
- Review the full text of the Distribution Agreement (Exhibit 1.1) for specific termination rights and price floor mechanisms.
- Check subsequent filings to determine if and when shares were actually sold under this agreement.
- Confirm the Company's current cash position and burn rate to understand the necessity of this capital raise.